Market Tracker

07/26 10:11am ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

36.20
BATS BZX Real-Time Price
As of 10:09am ET
 -0.11 / -0.30%
Today’s Change
16.64
Today|||52-Week Range
49.82
+1.54%
Year-to-Date
These 3 Biotechs Have Automatic Demand
Jul 23 / MotleyFool.com - Paid Partner Content
This Could Be the Next Big Pharma Buyout
Jul 18 / MotleyFool.com - Paid Partner Content
Investors Scour Big Pharma M&A Scene for Next Big Takeover
Jul 21 / TheStreet.com - Paid Partner Content
3 Risky Biotech Stocks That Could Make You Rich
Jul 12 / MotleyFool.com - Paid Partner Content
Strong On High Relative Volume: ACADIA Pharmaceuticals (ACAD)
Jul 20 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close36.31
Today’s open36.01
Day’s range35.60 - 36.48
Volume6,890
Average volume (3 months)3,140,190
Market cap$4.1B
Dividend yield--
Data as of 10:09am ET, 07/26/2016

Growth & Valuation

Earnings growth (last year)-71.58%
Earnings growth (this year)-10.20%
Earnings growth (next 5 years)+18.27%
Revenue growth (last year)-49.17%
P/E ratioNM
Price/Sales58,810.80
Price/Book18.53

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc+0.10+0.30%
ENDPEndo International P...+0.01+0.06%
ICPTIntercept Pharmaceut...+0.21+0.13%
GRFSGrifols SA-0.02-0.12%
Data as of 10:11am ET, 07/26/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$61.0K
Annual profit (last year)-$164.4M
Net profit margin-269,578.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts